FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Fried Jules Marc
2. Date of Event Requiring Statement (Month/Day/Year)
04/21/2016
3. Issuer Name and Ticker or Trading Symbol
Bionik Laboratories Corp. [BNKL]
(Last)
(First)
(Middle)
C/O INTERACTIVE MOTION TECHNOLOGIES, INC, 80 COOLIDGE HILL ROAD
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
VP - U.S. Operations
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

WATERTOWN, MA 02472
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, par value $0.001 per share 868,647 (1)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) 04/21/2016 06/02/2025 Common Stock, par value $0.001 per share 3,953 $ 0.95 D  
Employee Stock Option (Right to Buy) 04/21/2016 07/29/2025 Common Stock, par value $0.001 per share 906,077 $ 0.25 D  
Employee Stock Option (Right to Buy) 04/21/2016 06/02/2025 Common Stock, par value $0.001 per share 15,291 $ 1.05 D  
Employee Stock Option (Right to Buy) 04/21/2016 07/29/2025 Common Stock, par value $0.001 per share 671,857 $ 0.95 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Fried Jules Marc
C/O INTERACTIVE MOTION TECHNOLOGIES, INC
80 COOLIDGE HILL ROAD
WATERTOWN, MA 02472
      VP - U.S. Operations  

Signatures

/s/ Jules Fried 04/27/2016
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) 173,730 of such shares are held in escrow to satisfy potential indemnity claims under that certain Agreement and Plan of Merger dated March 1, 2016, by and among Bionik Laboratories Corp., Bionik Mergerco Inc., Hermano Igo Krebs and Interactive Motion Technologies, Inc.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.